Manhattan Scientifics, Inc. (MHTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 703 Thousand USD | 59.81% |
| 2022 | 729 Thousand USD | -1.09% |
| 2021 | 737 Thousand USD | 1.66% |
| 2020 | 725 Thousand USD | -35.38% |
| 2019 | 1.12 Million USD | -22.14% |
| 2018 | 1.44 Million USD | -35.41% |
| 2017 | 2.23 Million USD | -65.85% |
| 2016 | 6.53 Million USD | 3.45% |
| 2015 | 6.31 Million USD | 53.39% |
| 2014 | 4.11 Million USD | 67.36% |
| 2013 | 2.46 Million USD | 4.99% |
| 2012 | 2.34 Million USD | -14.64% |
| 2011 | 2.74 Million USD | 77.33% |
| 2010 | 1.54 Million USD | 50.29% |
| 2009 | 1.03 Million USD | -52.09% |
| 2008 | 2.15 Million USD | -37.55% |
| 2007 | 3.44 Million USD | 77.66% |
| 2006 | 1.93 Million USD | 19.78% |
| 2005 | 1.61 Million USD | -29.0% |
| 2004 | 2.27 Million USD | -25.74% |
| 2003 | 3.06 Million USD | -20.08% |
| 2002 | 3.84 Million USD | -40.3% |
| 2001 | 6.43 Million USD | 28.43% |
| 2000 | 5 Million USD | -47.49% |
| 1999 | 9.53 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 160 Thousand USD | -16.67% |
| 2024 Q1 | 192 Thousand USD | 27.15% |
| 2023 Q4 | 151 Thousand USD | -16.11% |
| 2023 Q1 | 186 Thousand USD | 6.9% |
| 2023 Q3 | 180 Thousand USD | -3.23% |
| 2023 Q2 | 186 Thousand USD | 0.0% |
| 2023 FY | 702 Thousand USD | -3.7% |
| 2022 Q4 | 174 Thousand USD | -1.69% |
| 2022 Q1 | 183 Thousand USD | 11.59% |
| 2022 FY | 729 Thousand USD | -1.09% |
| 2022 Q2 | 195 Thousand USD | 6.56% |
| 2022 Q3 | 177 Thousand USD | -9.23% |
| 2021 Q1 | 184 Thousand USD | 4.55% |
| 2021 Q3 | 178 Thousand USD | -15.64% |
| 2021 Q2 | 211 Thousand USD | 14.67% |
| 2021 FY | 737 Thousand USD | 1.66% |
| 2021 Q4 | 164 Thousand USD | -7.87% |
| 2020 Q2 | 178 Thousand USD | 3.49% |
| 2020 Q1 | 172 Thousand USD | 0.58% |
| 2020 Q4 | 176 Thousand USD | -11.56% |
| 2020 FY | 725 Thousand USD | -35.38% |
| 2020 Q3 | 199 Thousand USD | 11.8% |
| 2019 FY | 1.12 Million USD | -22.14% |
| 2019 Q4 | 171 Thousand USD | -10.0% |
| 2019 Q3 | 190 Thousand USD | -64.81% |
| 2019 Q2 | 540 Thousand USD | 144.34% |
| 2019 Q1 | 221 Thousand USD | -24.57% |
| 2018 Q4 | 293 Thousand USD | -9.01% |
| 2018 FY | 1.44 Million USD | -35.41% |
| 2018 Q3 | 322 Thousand USD | -18.27% |
| 2018 Q2 | 394 Thousand USD | -7.51% |
| 2018 Q1 | 426 Thousand USD | -30.84% |
| 2017 Q4 | 616 Thousand USD | 101.31% |
| 2017 FY | 2.23 Million USD | -65.85% |
| 2017 Q3 | 306 Thousand USD | 205.15% |
| 2017 Q2 | -291 Thousand USD | -118.19% |
| 2017 Q1 | 1.6 Million USD | 13.23% |
| 2016 Q4 | 1.41 Million USD | 9.79% |
| 2016 Q1 | 1.77 Million USD | 34.47% |
| 2016 FY | 6.53 Million USD | 3.45% |
| 2016 Q2 | 2.06 Million USD | 16.11% |
| 2016 Q3 | 1.28 Million USD | -37.55% |
| 2015 FY | 6.31 Million USD | 53.39% |
| 2015 Q4 | 1.32 Million USD | -25.68% |
| 2015 Q3 | 1.77 Million USD | -5.83% |
| 2015 Q2 | 1.88 Million USD | 41.49% |
| 2015 Q1 | 1.33 Million USD | 48.94% |
| 2014 FY | 4.11 Million USD | 67.36% |
| 2014 Q4 | 895 Thousand USD | 6.29% |
| 2014 Q3 | 842 Thousand USD | -25.09% |
| 2014 Q1 | 1.25 Million USD | 183.07% |
| 2014 Q2 | 1.12 Million USD | -10.51% |
| 2013 Q4 | -1.51 Million USD | -152.54% |
| 2013 Q3 | 2.87 Million USD | 296.97% |
| 2013 Q2 | 725 Thousand USD | 96.48% |
| 2013 Q1 | 369 Thousand USD | -42.97% |
| 2013 FY | 2.46 Million USD | 4.99% |
| 2012 Q4 | 647 Thousand USD | 24.9% |
| 2012 Q2 | 576 Thousand USD | -4.32% |
| 2012 Q1 | 602 Thousand USD | 12.1% |
| 2012 FY | 2.34 Million USD | -14.64% |
| 2012 Q3 | 518 Thousand USD | -10.07% |
| 2011 FY | 2.74 Million USD | 77.33% |
| 2011 Q4 | 537 Thousand USD | -55.1% |
| 2011 Q2 | 581 Thousand USD | 34.8% |
| 2011 Q3 | 1.19 Million USD | 105.85% |
| 2011 Q1 | 431 Thousand USD | 13.72% |
| 2010 FY | 1.54 Million USD | 50.29% |
| 2010 Q4 | 379 Thousand USD | -17.43% |
| 2010 Q2 | 435 Thousand USD | 38.98% |
| 2010 Q3 | 459 Thousand USD | 5.52% |
| 2010 Q1 | 313 Thousand USD | -60.38% |
| 2009 Q2 | 219 Thousand USD | -31.78% |
| 2009 Q1 | 321 Thousand USD | 18.01% |
| 2009 FY | 1.03 Million USD | -52.09% |
| 2009 Q3 | 240 Thousand USD | 9.59% |
| 2009 Q4 | 790 Thousand USD | 229.17% |
| 2008 Q1 | 1.29 Million USD | -20.41% |
| 2008 Q3 | 290 Thousand USD | -2.36% |
| 2008 FY | 2.15 Million USD | -37.55% |
| 2008 Q4 | 272 Thousand USD | -6.21% |
| 2008 Q2 | 297 Thousand USD | -76.99% |
| 2007 Q3 | 394 Thousand USD | -64.38% |
| 2007 FY | 3.44 Million USD | 77.66% |
| 2007 Q4 | 1.62 Million USD | 311.68% |
| 2007 Q2 | 1.1 Million USD | 244.55% |
| 2007 Q1 | 321 Thousand USD | 64.62% |
| 2006 Q3 | 310 Thousand USD | -70.25% |
| 2006 Q4 | 195 Thousand USD | -37.1% |
| 2006 Q2 | 1.04 Million USD | 165.82% |
| 2006 FY | 1.93 Million USD | 19.78% |
| 2006 Q1 | 392 Thousand USD | 22.88% |
| 2005 FY | 1.61 Million USD | -29.0% |
| 2005 Q1 | 510 Thousand USD | 3.24% |
| 2005 Q2 | 441 Thousand USD | -13.53% |
| 2005 Q3 | 348 Thousand USD | -21.09% |
| 2005 Q4 | 319 Thousand USD | -8.33% |
| 2004 Q2 | 660 Thousand USD | -13.04% |
| 2004 Q4 | 494 Thousand USD | 34.97% |
| 2004 Q1 | 759 Thousand USD | 6.15% |
| 2004 FY | 2.27 Million USD | -25.74% |
| 2004 Q3 | 366 Thousand USD | -44.55% |
| 2003 Q1 | 612 Thousand USD | -48.27% |
| 2003 FY | 3.06 Million USD | -20.08% |
| 2003 Q4 | 715 Thousand USD | 77.42% |
| 2003 Q3 | 403 Thousand USD | -69.9% |
| 2003 Q2 | 1.33 Million USD | 118.79% |
| 2002 Q4 | 1.18 Million USD | 86.01% |
| 2002 FY | 3.84 Million USD | -40.3% |
| 2002 Q2 | 615 Thousand USD | -56.26% |
| 2002 Q1 | 1.4 Million USD | 51.18% |
| 2002 Q3 | 636 Thousand USD | 3.41% |
| 2001 Q1 | 2.03 Million USD | 25.71% |
| 2001 FY | 6.43 Million USD | 28.43% |
| 2001 Q4 | 930 Thousand USD | -15.68% |
| 2001 Q3 | 1.1 Million USD | -53.36% |
| 2001 Q2 | 2.36 Million USD | 16.27% |
| 2000 Q3 | 1.34 Million USD | 27.11% |
| 2000 Q4 | 1.61 Million USD | 20.66% |
| 2000 Q1 | 994 Thousand USD | 0.0% |
| 2000 FY | 5 Million USD | -47.49% |
| 2000 Q2 | 1.05 Million USD | 6.14% |
| 1999 FY | 9.53 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | 5.087% |
| IR-Med Inc. | 4.89 Million USD | 85.635% |
| Polarean Imaging plc | 12.24 Million USD | 94.258% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 46.762% |
| Avitar, Inc. | 3.56 Million USD | 80.305% |
| AVITA Medical, Inc. | 80.77 Million USD | 99.13% |
| Össur hf. | 396.18 Million USD | 99.823% |
| Zecotek Photonics Inc. | 3.46 Million USD | 79.691% |
| QHSLab, Inc. | 961.65 Thousand USD | 26.897% |
| Wellstar International, Inc. | 1.79 Million USD | 60.829% |
| Össur hf. | 396.18 Million USD | 99.823% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 96.772% |
| Escalon Medical Corp. | 5.25 Million USD | 86.611% |
| Aurora Spine Corporation | 8.65 Million USD | 91.88% |
| BrainsWay Ltd. | 28.01 Million USD | 97.491% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 9.56 Million USD | 92.65% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 97.906% |
| Vivos Inc. | 2.78 Million USD | 74.777% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.933% |
| Kelyniam Global, Inc. | 2.27 Million USD | 69.102% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 30.732% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -61.424% |
| Nanomix Corporation | 8.36 Million USD | 91.599% |
| Theraclion SA | 7.43 Million USD | 90.551% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 45.697% |
| Positron Corporation | 1 Million USD | 30.208% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 77.399% |
| Lombard Medical, Inc. | 30.29 Million USD | 97.679% |
| ALR Technologies Inc. | 6.33 Million USD | 88.905% |
| Stratec SE | 46.32 Million USD | 98.482% |
| Vycor Medical, Inc. | 1.27 Million USD | 44.883% |
| Heart Tronics, Inc. | 14.46 Million USD | 95.138% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -483.277% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -240.569% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 95.032% |
| VMS Rehab Systems, Inc. | 63.63 USD | -1104724.768% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 79.874% |
| Ingen Technologies, Inc. | 1.88 Million USD | 62.651% |
| Odyssey Group International, Inc. | -14.26 Million USD | 104.93% |
| United American Healthcare Corporation | 59 Thousand USD | -1091.525% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -72.522% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -10.763% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 58.539% |
| Urologix, Inc. | 10.09 Million USD | 93.034% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 44.354% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 88.182% |
| SS Innovations International, Inc. | 21.38 Million USD | 96.712% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -205.332% |
| Smith & Nephew plc | 3.46 Billion USD | 99.98% |
| NIOX Group Plc | 22.27 Million USD | 96.844% |
| Fuse Medical, Inc. | 10.35 Million USD | 93.208% |
| Broncus Holding Corporation | 38.15 Million USD | 98.157% |
| Brain Scientific Inc. | 9.66 Million USD | 92.725% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 93.177% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -1058.193% |